Bisoprolol Fumarate

Bisoprolol Fumarate

Nazwa produktu Bisoprolol Fumarate
Numer CAS 104344-23-2
Wzór cząsteczkowy C18H31NO4 · ½ C4H4O4
Masa cząsteczkowa 766.96 g/mol (as fumarate salt)
Wygląd Biały lub prawie biały krystaliczny proszek
Oznaczenie (HPLC) 98.0% – 102.0% (on dried basis)
Strata przy suszeniu ≤ 0,5%
Popiół po spaleniu ≤ 0,11 TP3T
Metale ciężkie ≤ 10 ppm
Rozpuszczalność Sparingly soluble in water, freely soluble in methanol, slightly soluble in ethanol
Opakowanie 25 kg net in fiber drum with double polyethylene liner

Potrzebujesz pomocy? Skontaktuj się z naszym zespołem

Bisoprolol Fumarate Structure

Synonimy: Bisoprolol fumarate, 104344-23-2, EMD 33512, Bisoce, Bisoprolol hemifumarate, (±)-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol fumarate

Bisoprolol fumarate is a synthetic, cardioselective beta-1 adrenergic receptor blocker belonging to the aminoxypropanol class. It is supplied as a white to off-white crystalline powder, manufactured under cGMP conditions and tested to meet or exceed current pharmacopoeial standards (USP/EP).

As a highly selective beta-1 antagonist, bisoprolol fumarate is a cornerstone API for the treatment of hypertension, chronic stable angina, and heart failure. Its balanced lipophilicity and long half-life make it suitable for once-daily dosing, and it remains a preferred choice among healthcare professionals for cardiovascular management.

Product Highlights

  • High purity: ≥98.0% assay, with tight control on related substances and residual solvents.
  • Regulatory support: Available with DMF (Type II) and CEP, suitable for ANDA and generic filings.
  • Stable supply: Commercial-scale production with a current capacity of 20 metric tons per year.
  • Quality assurance: Each batch is fully traceable, with full documentation and retained samples.
  • Competitive pricing: Direct from manufacturer, offering cost advantages for bulk orders.

Zastosowania

  • Treatment of essential hypertension, either as monotherapy or in combination with other antihypertensives.
  • Management of chronic stable angina pectoris.
  • Adjunct therapy in stable chronic heart failure with reduced ejection fraction.
  • Formulation of immediate-release and fixed-dose combination tablets.
  • Research on beta-adrenergic receptor pharmacology and cardiovascular therapeutics.

Dane techniczne

Parametr Specyfikacja
Assay (HPLC, dried basis) 98.0% – 102.0%
Wygląd Biały lub prawie biały krystaliczny proszek
Identyfikacja IR and HPLC retention time match reference standard
Strata przy suszeniu ≤ 0,5%
Popiół po spaleniu ≤ 0,11 TP3T
Metale ciężkie ≤ 10 ppm
Substancje pokrewne Each impurity ≤ 0.5%, total ≤ 1.0%

Ordering & Supply

  • Opakowanie: 25 kg net in fiber drum with double polyethylene liner; custom packaging available upon request.
  • MOQ: 1 kg for trial orders; 25 kg for commercial orders.
  • Czas realizacji: 3–5 dni roboczych (towary dostępne w magazynie)
  • Dokumentacja: COA, MSDS, TDS, and regulatory support (DMF, CEP) provided with each shipment.

Zapytanie ofertowe

BĄDŹ W KONTAKCIE

Zapytanie ofertowe

Nasz adres

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×